Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Navidea Biopharmaceuticals Inc    

 SummaryNewsCalendarCompanyFinancials 
Company
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic.It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and... 
More about the company
Latest news on NAVIDEA BIOPHARMACEUTICALS
12:07p NAVIDEA BIOPHARMACEUTICALS, INC. : Other Events (form 8-K)
05/16 NAVIDEA BIOPHARMACEUTICALS, INC. (NY : NAVB) Files An 8-K Other Events
05/16 NAVIDEA BIOPHARMACEUTICALS, INC. : Other Events (form 8-K)
05/10 NAVIDEA BIOPHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
05/10 NAVIDEA BIOPHARMACEUTICALS : posts 1Q profit
05/09 NAVIDEA BIOPHARMACEUTICALS, INC. : Results of Operations and Financial Condition..
05/09 NAVIDEA BIOPHARMACEUTICALS, INC. (NY : NAVB) Files An 8-K Results of Operations ..
05/09 NAVIDEA BIOPHARMACEUTICALS : Reports First Quarter 2017 Financial Results
05/01 NAVIDEA BIOPHARMACEUTICALS, INC. : Change in Directors or Principal Officers (fo..
04/25 NAVIDEA BIOPHARMACEUTICALS : Invited to Present Data at Two Major Upcoming Confe..
More news
Sector news : Biotechnology & Medical Research - NEC
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/20 Navidea inks commercialization deal in India for Tc 99m tilmanocept; shares u..
06/12 Navidea's commercial partner launches Lymphoseek in Europe
05/16 Navidea pays over $600K to former CEO after losing arbitration
05/09 Navidea Biopharm reports Q1 results
03/29 Navidea Biopharm reports Q4 results
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Mike M. Goldberg President, Chief Executive Officer & Director
Eric K. Rowinsky Chairman
Jed Andrew Latkin CFO, COO, Secretary & Treasurer
Frederick O. Cope Chief Scientific Officer & Senior Vice President
Mark I. Greene Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NAVIDEA BIOPHARMACEUTI..84
INCYTE CORPORATION33.97%27 507
QUINTILES IMS HOLDINGS..19.12%19 551
LONZA GROUP27.12%16 118
CELLTRION, INC.--.--%12 272
ALKERMES PLC4.64%8 910
More Results